Advocacy
How are we advocating for Kidney Cancer? Find out HERE
In the News
What’s the latest in the news regarding Kidney Cancer? Read below
$30 Million for Kidney Cancer Research
The U.S. House Appropriations Committee released its report accompanying the FY20 Defense Appropriations Act. It contains an increase to $30 million annually for the kidney cancer research program. Led by KidneyCan, a coalition of
IKCC Global Kidney Cancer Summit 2019
Our President, Bryan Lewis represented KidneyCan at the 9th global summit for Kidney Cancer in Lisbon, Portugal. IKCC (International Kidney Cancer Coalition) hosted the event and is an international patient advocacy organization for kidney
First In Human Trial for Kidney Cancer: Watching and Waiting
The treatment part of this Phase 1 clinical trial for kidney cancer is over, now we're in the watching and waiting phase. My husband, Ralph, is patient #3 in a first in human clinical trial
Clinical trials are vital to Medical Research
My husband is participating in a first in human or Phase 1 clinical trial. This trial is for kidney cancer and being conducted at The National Institutes of Health (NIH). I'll be writing about
NCI Leader in Kidney Cancer
Bryan Lewis, Ralph & Brenda Knapp, founders of KidneyCan had the pleasure of sitting down with NCI leader in Kidney Cancer, Dr. Rampasad (‘Ram’) Srinivasan. It was exciting to
Letter submitted to Congressional Leadership
KidneyCan submitted a letter to the Congressional leadership of the House Appropriations Committee in early March. The letter was hand delivered by KidneyCan's President, Bryan Lewis to the various leadership offices on Monday, March
